Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Henry Schein Inc. closed $12.62 short of its 52-week high ($82.63), which the company reached on February 27th.

Despite modest sales growth, Henry Schein Inc (HSIC) boosts EPS guidance and expands its global e-commerce platform.

On Tuesday, Henry Schein Inc. (NASDAQ:HSIC) reported a third-quarter adjusted EPS of $1.22, down 7.6% year-over-year, beating ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Q3 2024 Earnings Call Transcript November 5, 2024 Henry Schein, Inc. beats earnings expectations. Reported EPS is $1.22, ...

Gulf International Bank UK Ltd trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 3.1% in the 3rd ...

Robert W. Baird analyst Jeff Johnson reiterated a Buy rating on Henry Schein (HSIC – Research Report) on November 5 and set a price ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

The health care products maker posted revenue of $3.17 billion in the period, which missed Street forecasts. Nine analysts surveyed by Zacks expected $3.24 billion. Henry Schein expects full-year ...

On Wednesday, Henry Schein, Inc. (HSIC) stock saw a modest uptick, ending the day at $70.01 which represents a slight increase of $1.02 or 1.48% from the prior close of $68.99. The stock opened at $71 ...